ADMA Share Price

ADMA Share Price

NASDAQ: ADMA | Mid Cap | Healthcare
$13.57
-$0.06 (-0.44%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

ADMA Stock Performance

Open
$13.63
Prev. Close
$13.63
Circuit Range
N/A
Day Range
$13.54 - $14.20
Year Range
$7.23 - $20.43
Volume
2,51,520
Average Traded
$13.93

ADMA Share Price Today

As of 19 November 2026, ADMA Biologics Inc's share price is $13.57. The stock opened at $13.63, compared to its previous close of $13.63. During today's trading session, ADMA Biologics Inc's share price traded between $13.54 and $14.20, with an average price of $13.87. Over the past 52 weeks, the stock has recorded a high of $20.43 and a low of $7.23. In terms of performance, ADMA Biologics Inc's share price has risen by 70.48% over the last six months and is down 29.21% on a year-on-year basis.

ADMA Share Price Chart

Line chart of the ADMA price trend over the selected period. The price fell overall, ranging from 13.54 to 14.13, ending at 13.57.
$13.54$14.20
L
Show Current Price
H

ADMA Stock Fundamentals & Key Indicators

Market Cap
$3.23B
PE Ratio (TTM)
16.58
Dividend Yield
0.00%
EPS (TTM)
$0.82
Revenue (TTM)
$510.17B
Return On Equity (TTM)
41.60%
Profit Margin
28.80%
Debt to Equity
0.45
Quarterly Earnings Growth YoY
1.01%

ADMA Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$139.16$114.49$124.40$141.10
Net Profit$49.38$45.33$37.82$49.88
Net Profit Margin35.48%39.59%30.40%35.35%
Income ChangeN/A-8.20%-16.57%31.89%

ADMA Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$154.08$258.22$426.45$510.17
Net Profit-$65.90-$28.24$197.67$146.93
Net Profit Margin-42.77%-10.94%46.35%28.80%
Income ChangeN/A57.15%799.96%-25.67%

ADMA Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets157.73157.2772.1778.06
Current Assets466.51331.41257.01270.4
Total Assets624.24488.68329.18348.46
Non Current Liabilities80.0384.12144.17157.22
Current Liabilities66.8955.5449.8139.27
Total Liabilities146.92139.66193.98196.49
Shareholders' Equity477.32349.02135.21151.97

ADMA Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating50.4118.678.8-59.51
Investing-21.89-8.58-4.98-13.91
Financing-44.02-58.3-38.99108.85

About ADMA

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

ADMA Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$11.44
$13.56
+19.36%
Oct 2026
$10.07
$11.37
+12.97%
Sep 2026
$9.40
$10.06
+6.12%
Aug 2026
$8.61
$9.48
+12.06%
Jul 2026
$8.57
$8.46
+1.01%
Jun 2026
$7.96
$8.38
+5.21%
May 2026
$10.40
$7.96
-22.27%
Apr 2026
$9.04
$10.24
+13.90%
Mar 2026
$15.74
$8.99
-42.28%
Feb 2026
$17.23
$15.57
-9.92%
Jan 2026
$18.44
$17.29
-5.16%
Dec 2025
$18.94
$18.23
-4.90%

ADMA Share Price FAQs